207 related articles for article (PubMed ID: 25985958)
1. Venous thromboembolism (VTE) and glioblastoma.
Yust-Katz S; Mandel JJ; Wu J; Yuan Y; Webre C; Pawar TA; Lhadha HS; Gilbert MR; Armstrong TS
J Neurooncol; 2015 Aug; 124(1):87-94. PubMed ID: 25985958
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Venous Thromboembolism in Patients with Glioblastoma.
Nabi S; Kahlon P; Bozorgnia F; Arshad A; Mikkelsen T; Donthireddy V
Pathol Oncol Res; 2016 Apr; 22(2):311-6. PubMed ID: 26547860
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J; de la Rocha IV; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M;
Thromb Res; 2015 Dec; 136(6):1199-203. PubMed ID: 26548619
[TBL] [Abstract][Full Text] [Related]
4. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
5. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
[TBL] [Abstract][Full Text] [Related]
6. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients.
Wang R; Liu R; Zhao L; Xu D; Hu L
Rev Esp Enferm Dig; 2017 Jul; 109(7):503-509. PubMed ID: 28593781
[TBL] [Abstract][Full Text] [Related]
7. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR
World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
9. A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.
Streiff MB; Ye X; Kickler TS; Desideri S; Jani J; Fisher J; Grossman SA
J Neurooncol; 2015 Sep; 124(2):299-305. PubMed ID: 26100546
[TBL] [Abstract][Full Text] [Related]
10. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients.
Hiraide M; Shiga T; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Yasuda C; Takahashi H; Hama T
J Cardiol; 2020 Jan; 75(1):110-114. PubMed ID: 31416782
[TBL] [Abstract][Full Text] [Related]
11. Retrospective study of venous thromboembolic and intracerebral hemorrhagic events in glioblastoma patients.
Pan E; Tsai JS; Mitchell SB
Anticancer Res; 2009 Oct; 29(10):4309-13. PubMed ID: 19846992
[TBL] [Abstract][Full Text] [Related]
12. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
13. Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
Vathiotis I; Dimakakos EP; Boura P; Ntineri A; Charpidou A; Gerotziafas G; Syrigos K
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1347-1351. PubMed ID: 29806470
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'.
Mandala M; Clerici M; Corradino I; Vitalini C; Colombini S; Torri V; De Pascale A; Marsoni S
Ann Oncol; 2012 Jun; 23(6):1416-21. PubMed ID: 22052988
[TBL] [Abstract][Full Text] [Related]
15. Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Heenkenda MK; Malmström A; Lysiak M; Mudaisi M; Bratthäll C; Milos P; Strandeus M; Åkesson L; Söderkvist P; Uppugunduri S; Osman A
Thromb Res; 2019 Nov; 183():136-142. PubMed ID: 31677594
[TBL] [Abstract][Full Text] [Related]
16. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
17. PO-03 - Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL).
Santi RM; Ceccarelli M; Catania G; Monagheddu C; Evangelista A; Bernocco E; Monaco F; Federico M; Vitolo U; Cortelazzo S; Cabras MG; Spina M; Baldini L; Boccomini C; Chiappella A; Bari A; Luminari S; Calabrese M; Levis A; Visco C; Contino L; Ciccone G; Ladetto M
Thromb Res; 2016 Apr; 140 Suppl 1():S177. PubMed ID: 27161692
[TBL] [Abstract][Full Text] [Related]
18. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
